David A. Giljohann
Directeur Général chez EVOQ Therapeutics, Inc.
Postes actifs de David A. Giljohann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
EVOQ Therapeutics, Inc.
 EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Directeur Général | 09/01/2023 | - |
Historique de carrière de David A. Giljohann
Anciens postes connus de David A. Giljohann
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| EXICURE, INC. | Directeur/Membre du Conseil | 01/03/2014 | 10/12/2021 |
| Directeur Général | 01/11/2013 | 10/12/2021 | |
| Directeur des opérations | 01/07/2012 | 01/10/2013 | |
| Directeur Technique/Scientifique/R&D | 10/12/2021 | 31/01/2022 | |
| Directeur Financier/CFO | 30/09/2020 | 13/05/2021 | |
| Secrétaire Général | 30/09/2020 | 10/12/2021 | |
| Aurasense LLC | Directeur Technique/Scientifique/R&D | - | 01/01/2009 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Directeur/Membre du Conseil | 01/03/2014 | - |
| Directeur Général | 01/11/2013 | - | |
| Directeur des opérations | 30/07/2012 | 01/10/2013 | |
| Corporate Officer/Principal | 01/01/2011 | 01/06/2012 |
Formation de David A. Giljohann
| Northwestern University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Chief Operating Officer | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXICURE, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Aurasense LLC | |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology EVOQ Therapeutics LLC operates as a biopharmaceutical company, which engages in developing new vaccine technologies for improving outcomes for cancer patients. The company was founded by William Brinkerhoff, James Moon, and Anna Schwendeman in 2016 and is headquartered in Ann Arbor, MI. | Health Technology |
- Bourse
- Insiders
- David A. Giljohann
- Expérience
